AZTA
Azenta, Inc.
Overview
Azenta provides automated sample storage systems, cryogenic freezers, sample management services, and genomic sequencing and synthesis services to pharmaceutical, biotechnology, and research institutions.
Azenta, Inc is a Healthcare company operating in Medical Instruments & Supplies with a $1.03B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-02-0415 Q&A exchanges
- Q4 FY2025Earnings2025-11-2119 Q&A exchanges
- Q3 FY2025Earnings2025-08-0516 Q&A exchanges
- Q2 FY2025Earnings2025-05-0717 Q&A exchanges
- Q1 FY2025Earnings2025-02-0514 Q&A exchanges
- Q4 FY2024Earnings2024-11-1234 Q&A exchanges
- Q3 FY2024Earnings2024-08-0610 Q&A exchanges
- Q2 FY2024Earnings2024-05-0817 Q&A exchanges
- Q1 FY2024Earnings2024-02-0721 Q&A exchanges
- Q4 FY2023Earnings2023-11-1328 Q&A exchanges
- Q3 FY2023Earnings2023-08-0811 Q&A exchanges
- Q2 FY2023Earnings2023-05-0813 Q&A exchanges
- Q1 FY2023Earnings2023-02-1018 Q&A exchanges
- Q4 FY2022Earnings2022-11-1415 Q&A exchanges
- Q3 FY2022Earnings2022-08-0917 Q&A exchanges
- Q2 FY2022Earnings2022-05-0918 Q&A exchanges
- Q1 FY2022Earnings2022-02-088 Q&A exchanges
- Q4 FY2021Earnings2021-11-106 Q&A exchanges
- Q3 FY2021Earnings2021-08-0510 Q&A exchanges
- Q2 FY2021Earnings2021-05-1117 Q&A exchanges
- Q1 FY2021Earnings2021-02-0214 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $0.10—Rev— vs ——EODHD
- Q1 FY20262026-05-10EPS$-0.04 vs $0.15-100.0%Rev$144.8M vs ——EODHD
- Q4 FY20252026-02-03EPS$0.09 vs $0.14-34.0%Rev$148.6M vs ——EODHD
- Q3 FY20252025-11-10EPS$0.21 vs $0.20+5.0%Rev$159.2M vs ——EODHD
- Q2 FY20252025-08-04EPS$0.19 vs $0.14+35.7%Rev$143.9M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.05 vs $0.07-28.6%Rev$143.4M vs ——EODHD
- Q4 FY20242025-02-04EPS$0.08 vs $0.06+33.3%Rev$147.4M vs ——EODHD
- Q3 FY20242024-11-11EPS$0.18 vs $0.11+63.6%Rev$150.6M vs ——EODHD
- Q2 FY20242024-08-05EPS$0.16 vs $0.07+100.0%Rev$144.3M vs ——EODHD
- Q1 FY20242024-05-07EPS$0.05 vs $0.02+100.0%Rev$136.4M vs ——EODHD
- Q4 FY20232024-02-06EPS$0.02 vs $-0.03+100.0%Rev$141.7M vs ——EODHD
- Q3 FY20232023-11-12EPS$0.13 vs $0.02+100.0%Rev$172.4M vs ——EODHD
- Q2 FY20232023-08-07EPS$0.13 vs $-0.02+100.0%Rev$165.9M vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.06 vs $-0.02-100.0%Rev$148.4M vs ——EODHD
- Q4 FY20222023-02-07EPS$0.12 vs $0.08+50.0%Rev$178.4M vs ——EODHD
- Q3 FY20222022-11-13EPS$0.16 vs $0.07+100.0%Rev$137.6M vs ——EODHD
- Q2 FY20222022-08-08EPS$0.12 vs $0.10+20.0%Rev$132.7M vs ——EODHD
- Q1 FY20222022-05-08EPS$0.12 vs $0.11+9.1%Rev$145.5M vs ——EODHD
- Q4 FY20212022-02-07EPS$0.12 vs $0.08+50.0%Rev$139.7M vs ——EODHD
- Q3 FY20212021-11-09EPS$0.78 vs $0.77+1.3%Rev$136.9M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $0.10 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-10 | $-0.04 | $0.15 | -100.0% | $144.8M | — | — | EODHD |
| Q4 FY2025 | 2026-02-03 | $0.09 | $0.14 | -34.0% | $148.6M | — | — | EODHD |
| Q3 FY2025 | 2025-11-10 | $0.21 | $0.20 | +5.0% | $159.2M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $0.19 | $0.14 | +35.7% | $143.9M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.05 | $0.07 | -28.6% | $143.4M | — | — | EODHD |
| Q4 FY2024 | 2025-02-04 | $0.08 | $0.06 | +33.3% | $147.4M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $0.18 | $0.11 | +63.6% | $150.6M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $0.16 | $0.07 | +100.0% | $144.3M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $0.05 | $0.02 | +100.0% | $136.4M | — | — | EODHD |
| Q4 FY2023 | 2024-02-06 | $0.02 | $-0.03 | +100.0% | $141.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $0.13 | $0.02 | +100.0% | $172.4M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $0.13 | $-0.02 | +100.0% | $165.9M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.06 | $-0.02 | -100.0% | $148.4M | — | — | EODHD |
| Q4 FY2022 | 2023-02-07 | $0.12 | $0.08 | +50.0% | $178.4M | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $0.16 | $0.07 | +100.0% | $137.6M | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $0.12 | $0.10 | +20.0% | $132.7M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $0.12 | $0.11 | +9.1% | $145.5M | — | — | EODHD |
| Q4 FY2021 | 2022-02-07 | $0.12 | $0.08 | +50.0% | $139.7M | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $0.78 | $0.77 | +1.3% | $136.9M | — | — | EODHD |
Source: EODHD. AZTA reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks AZTA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.88 | $1.02 | -13.4% | +3.6% | +5.8% |
| Q4 FY2026 | $0.86 | $1.01 | -15.2% | +0.3% | +1.0% |
| Q3 FY2026 | $0.67 | $0.81 | -17.6% | +3.0% | +5.6% |
| Q2 FY2026 | $0.84 | $0.96 | -12.1% | +1.4% | -0.7% |
| Q1 FY2025 | $1.02 | $1.13 | -9.7% | -4.2% | -2.1% |
| Q4 FY2025 | $0.92 | $1.04 | -11.4% | -3.6% | -6.0% |
| Q3 FY2025 | $1.03 | $1.14 | -9.6% | -7.6% | -10.1% |
| Q2 FY2025 | $0.84 | $1.03 | -18.5% | +1.9% | -0.5% |
| Q1 FY2024 | $0.92 | $1.01 | -8.9% | +2.6% | +4.1% |
| Q4 FY2024 | $0.90 | $1.03 | -12.8% | -3.8% | -2.6% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- John MarottaCEO1 yr 1 mo6 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last call held guidance Q2 FY2026
- Lawrence Y LinCFO1 yr 1 mo3 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- William E Martin IIIPresident2 mono recorded callsCurrentSample
PRESIDENT since 2026 • 1/2 beats (50%) • guidance suspended Q1 FY2026
- Olga PirogovaSVP and CHRO10 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
- Ginger ZhouSVP and GM, Multiomics10 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • last guidance cut Q1 FY2026
- Ephraim StarrSVP, Gen Counsel & Secretary1 yr 1 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • last call held guidance Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AZTA.
$ curl https://api.spokenalpha.com/v1/companies/AZTAFAQ
Frequently asked about AZTA
Where can I find Azenta, Inc.'s (AZTA) earnings call transcripts?
Spoken Alpha indexes AZTA's earnings call transcripts at https://spokenalpha.com/companies/AZTA. Each call links to attributed speakers and parsed analyst Q&A. Azenta, Inc.'s own investor relations page is at https://investors.azenta.com/.
When was Azenta, Inc.'s most recent earnings call?
Azenta, Inc. (AZTA) held its most recent earnings call on 2026-02-04, covering fiscal Q1 2026.
What sector is AZTA in?
Azenta, Inc. (AZTA) operates in the Healthcare sector (Medical Instruments & Supplies industry).